Viewing Study NCT06855095


Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2025-12-24 @ 1:16 PM
Study NCT ID: NCT06855095
Status: RECRUITING
Last Update Posted: 2025-03-03
First Post: 2023-10-25
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
Sponsor: The Netherlands Cancer Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-06-25
Start Date Type: ACTUAL
Primary Completion Date: 2027-01-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-03-01
Completion Date Type: ESTIMATED
First Submit Date: 2023-10-25
First Submit QC Date: None
Study First Post Date: 2025-03-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-02-26
Last Update Post Date: 2025-03-03
Last Update Post Date Type: ACTUAL